Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Chart Industries, Dover, Flowserve, AZZ and Manitowoc

Read MoreHide Full Article

For Immediate Release

Chicago, IL – June 19, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Chart Industries Inc. (GTLS - Free Report) , Dover Corp. (DOV - Free Report) , Flowserve Corp. (FLS - Free Report) , AZZ Inc. (AZZ - Free Report) and The Manitowoc Co Inc. (MTW - Free Report) .

Here are highlights from Tuesday’s Analyst Blog:

5 Top Picks on Strong Industrial Production

U.S. industrial production recorded its highest gain in May since December 2018. Most importantly, U.S. manufacturing output registered its first monthly gain of 2019. A strong and broad-based gain in U.S. factory output provided some respite to concern that the manufacturing sector is cooling in the face of a lingering trade war with China and slowdown in the global economy.

Moreover, capacity utilization edged up in overall industrial production and the manufacturing sector, indicating higher industrial activities. At this stage, it will be prudent to invest in manufacturing stocks with a favorable Zacks Rank and strong growth potential.

Robust Industrial Production Data in May

On Jun 14, the Federal Reserve reported that U.S. industrial production increased by 0.4% in May, highest in six months. The figure was also above the consensus estimate of growth of 0.2%. In April, industrial production contracted by 0.4%. Industrial Production rose 2% year over year in May.

Across the board, all major market groups, such as, consumer goods, business equipment, nonindustrial supplies, construction and materials rose 0.5%, 0.2%, 0.4%, 0.2% and 0.3%, respectively. Sector wise, manufacturing, mining and utilities grew 0.2%, 0.1% and 2.1%, respectively.

Overall capacity utilization was 78.1% in May compared with 77.9% in April. However, capacity utilization is still 1.7% below the average figure of 79.8% for the 1972-2018 period. This indicates that a solid ground for growth of industrial production still exists without affecting inflation. This is a key metric for the Fed to consider while taking decisions on interest rate.

Manufacturing Output Returns to Growth Trajectory

The most-important inference from the industrial production data of May is the rebound of U.S. manufacturing sector. This sector registered growth of 0.2%, marking its first monthly gain in 2019. In January and February, U.S. manufacturing declined by 0.6%. In March, this sector remained unchanged only to decline again in April by 0.5%.

In May, solid 2.4% growth of motor vehicles and parts more than offset 1.9% decline in primary metals and 0.1% drop in fabricated metals. Light truck assemblies increased to 8.43 million from 7.84 million in April. Auto assemblies grew to 2.56 million from 2.44 million in April. Capacity utilization of manufacturing sector also edged up to 75.7% from 75.6% in the previous month. However, the figure still 2.6% behind its average 78.3% for the period 1972-2018.

Notably, the manufacturing sector constituted nearly 12% of U.S. GDP. A weak ISM manufacturing index for May and tepid industrial production data of China in May, which fell to its 17-year low level, compelled several economists to consider that manufacturing activities are slowing globally, which is affecting U.S. industrial products. However, the industrial production data for May eased the concerns to some extent.

Our Top Picks  

Considering the above-mentioned factors, we narrowed down our search to five manufacturing stocks with a strong growth potential. Each of these stocks carry either a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

The chart below shows price performance of our five picks year to date.

Chart Industries Inc. manufactures and sells engineered equipment and packaged solutions and provides value-add services for the energy and industrial gas industries worldwide. It sports a Zacks Rank #1. The company has expected earnings growth rate of 51.5% for the current year. The Zacks Consensus Estimate for the current year has improved 3.7% over the last 60 days.

Dover Corp. provides equipment and components, specialty systems, consumable supplies, software and digital solutions, and support services worldwide. It carries a Zacks Rank #2. The company has expected earnings growth rate of 16.9% for the current year. The Zacks Consensus Estimate for the current year has improved 1% over the last 60 days.

Flowserve Corp. designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia and internationally. It carries a Zacks Rank #2. The company has expected earnings growth rate of 25.1% for the current year. The Zacks Consensus Estimate for the current year has improved 2.3% over the last 60 days.

AZZ Inc. provides galvanizing and metal coating services, welding solutions, specialty electrical equipment and highly engineered services to the power generation, transmission, distribution, refining and industrial markets. It has a Zacks Rank #2. The company has expected earnings growth rate of 32.1% for the current year. The Zacks Consensus Estimate for the current year has improved 2.8% over the last 60 days.

The Manitowoc Co Inc. provides engineered lifting equipment for the construction industry in the Americas, Europe, Africa, the Middle East, and the Asia Pacific. It has a Zacks Rank #2. The company has an expected earnings growth rate of 117.2% for the current year. The Zacks Consensus Estimate for the current year has improved 6.1% over the last 60 days.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They're also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact                                               

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

http://www.zacks.com                                                   

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in